血清性激素结合球蛋白介导肝内脂质含量与2型糖尿病之间的关联:马斯特里赫特研究
基于马斯特里赫特研究(n=1554)的横断面数据,采用3T Dixon MRI测量肝内脂质含量,口服葡萄糖耐量试验评估2型糖尿病,中介分析显示血清性激素结合球蛋白(SHBG)介导肝内脂质含量与2型糖尿病的关联,女性中介比例为50.9%,男性为17.2%。
要点
- 肝内脂质含量与2型糖尿病显著相关:女性OR 1.08(95%CI 1.04,1.14),男性OR 1.12(95%CI 1.08,1.17)。
- 血清SHBG显著中介肝内脂质与2型糖尿病的关联:女性中介比例50.9%(95%CI 26.7,81.3),男性17.2%(95%CI 9.6,27.6)。
- 女性中SHBG的中介贡献高于男性:女性OR 1.04(95%CI 1.02,1.07)vs 男性OR 1.02(95%CI 1.01,1.03)。
核心结论
- 在这项大型人群队列研究中,血清SHBG被发现在肝内脂质含量与2型糖尿病的关联中起中介作用。
研究设计与样本
- 马斯特里赫特研究的横断面数据,人群队列研究,对2型糖尿病患者进行过采样,样本量n=1554。
- 2型糖尿病状态通过口服葡萄糖耐量试验评估,肝内脂质含量使用3T Dixon MRI测量。
- 采用中介分析评估血清SHBG在肝内脂质含量与2型糖尿病关联中的中介作用。
主要发现
- 肝内脂质含量与2型糖尿病显著相关:女性OR 1.08(95%CI 1.04,1.14),男性OR 1.12(95%CI 1.08,1.17)。
- 血清SHBG显著中介肝内脂质含量与2型糖尿病的关联:女性OR 1.04(95%CI 1.02,1.07),中介比例50.9%(95%CI 26.7,81.3)。
- 男性中血清SHBG的中介作用:OR 1.02(95%CI 1.01,1.03),中介比例17.2%(95%CI 9.6,27.6)。
- 使用2型糖尿病替代指标和调整协变量后的重复分析未实质性影响结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: Serum sex hormone-binding globulin (SHBG) has been proposed to act as a hepatokine that contributes to the extrahepatic complications observed in non-alcoholic fatty liver disease (NAFLD). However, it remains uncertain whether serum SHBG mediates the association between intrahepatic lipids (IHL) and type 2 diabetes. Therefore, we studied whether, and to what extent, serum SHBG mediates the association between IHL content and type 2 diabetes. METHODS: We used cross-sectional data from the Maastricht Study (n=1554), a population-based cohort study with oversampling of individuals with type 2 diabetes. Type 2 diabetes status was assessed by oral glucose tolerance test, and IHL content was measured using 3T Dixon MRI. Mediation analyses were performed to assess the role of serum SHBG in mediating the association between IHL content and type 2 diabetes. RESULTS: IHL content was significantly associated with type 2 diabetes in women and men (OR 1.08 [95% CI 1.04, 1.14] and OR 1.12 [95% CI 1.08, 1.17], respectively). Serum SHBG significantly mediated the association between IHL content and type 2 diabetes. The contribution of serum SHBG was higher in women (OR 1.04 [95% CI 1.02, 1.07]; proportion mediated 50.9% [95% CI 26.7, 81.3]) than in men (OR 1.02 [95% CI 1.01, 1.03]; proportion mediated 17.2% [95% CI 9.6, 27.6]). Repeat analyses with proxies of type 2 diabetes and adjustment for covariates did not substantially affect the results. CONCLUSIONS/INTERPRETATION: In this large-scale population-based cohort study, serum SHBG was found to be a mediator of the association between IHL content and type 2 diabetes. These findings extend our understanding of the potential mechanisms by which NAFLD is a risk factor for type 2 diabetes, and further elaborate on the role of SHBG as a hepatokine.
引用
- Simons PIHG, Valkenburg O, van de Waarenburg MPH, et al. Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study. Diabetologia. 2022. PMID: 36114428. doi:10.1007/s00125-022-05790-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。